Skip to Content

Drug Sensitivity Screening to Guide Clinical Decisions for Hematologic Cancers

This study focused on optimizing and validating drug screening protocols for hematologic malignancies and using them to guide treatment decisions in active clinical trials.

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top